The newest addition to the University of Minnesota’s Biomedical Discovery District (BDD) – our Cancer/Cardiovascular Building – continues to progress toward completion.
When complete, the Lillehei Heart Institute and the Department of Integrative Biology and Physiology will relocate 20-25 investigators to the facility to continue their work in cardiac regeneration, cardiac development, muscular dystrophy, congenital heart medicine and genomics.
Going forward, the groups plan to add nearly four investigators per year to the new building.
The Masonic Cancer Center plans to utilize the new space for two specific groups of investigators: chemical biologists focusing on studying chemical carcinogens as a cause of cancer and faculty focusing on novel new therapeutic strategies to fight cancer.
The arrangements will build on collaborations already underway with researchers in two other Biomedical Discovery District buildings – the Winston and Maxine Wallin Medical Biosciences Building (WMBB) and the Center for Magnetic Resonance Research (CMRR).
By relocating researchers to the new facility, both Lillehei Heart Institute and Masonic Cancer Center researchers will capitalize on existing partnerships while expanding into the type of laboratory space required for a new era of scientific discovery.
Stay tuned to Health Talk for more on the Biomedical Discovery District going forward.